Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1970 1
1971 1
1972 6
1973 7
1974 7
1975 5
1976 7
1977 7
1978 15
1979 15
1980 11
1981 19
1982 14
1983 22
1984 25
1985 24
1986 36
1987 44
1988 31
1989 29
1990 20
1991 18
1992 27
1993 21
1994 24
1995 29
1996 20
1997 16
1998 15
1999 15
2000 20
2001 15
2002 14
2003 13
2004 9
2005 3
2006 5
2007 1
2008 3
2011 1
2012 2
2013 2
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

619 results
Results by year
Filters applied: . Clear all
Page 1
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group. Julius S, et al. Among authors: brunner hr. Lancet. 2004 Jun 19;363(9426):2022-31. doi: 10.1016/S0140-6736(04)16451-9. Lancet. 2004. PMID: 15207952 Clinical Trial.
Angiotensin II antagonists.
Brunner HR, Nussberger J, Burnier M, Waeber B. Brunner HR, et al. Clin Exp Hypertens. 1993 Nov;15(6):1221-38. doi: 10.3109/10641969309037107. Clin Exp Hypertens. 1993. PMID: 8268887 Review.
Compliance with antihypertensive therapy.
Waeber B, Burnier M, Brunner HR. Waeber B, et al. Among authors: brunner hr. Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):973-85. doi: 10.3109/10641969909061025. Clin Exp Hypertens. 1999. PMID: 10423118 Review.
Angiotensin II receptor antagonists.
Burnier M, Brunner HR. Burnier M, et al. Among authors: brunner hr. Lancet. 2000 Feb 19;355(9204):637-45. doi: 10.1016/s0140-6736(99)10365-9. Lancet. 2000. PMID: 10696996 Review.
Cardiovascular effects of neuropeptide Y.
Waeber B, Aubert JF, Corder R, Evéquoz D, Nussberger J, Gaillard R, Brunner HR. Waeber B, et al. Among authors: brunner hr. Am J Hypertens. 1988 Apr;1(2):193-9. doi: 10.1093/ajh/1.2.193. Am J Hypertens. 1988. PMID: 3041996 Review.
Neuropeptide Y and cardiovascular regulation.
Pedrazzini T, Brunner HR, Waeber B. Pedrazzini T, et al. Among authors: brunner hr. Curr Opin Nephrol Hypertens. 1993 Jan;2(1):106-13. doi: 10.1097/00041552-199301000-00016. Curr Opin Nephrol Hypertens. 1993. PMID: 7922157 Review.
First-line pharmacological treatment of hypertension.
Burnier M, Waeber B, Brunner HR. Burnier M, et al. Among authors: brunner hr. J Intern Med. 1992 Nov;232(5):381-8. doi: 10.1111/j.1365-2796.1992.tb00603.x. J Intern Med. 1992. PMID: 1453121 Review. No abstract available.
Clinical efficacy of olmesartan medoxomil.
Brunner HR, Laeis P. Brunner HR, et al. J Hypertens Suppl. 2003 May;21(2):S43-6. doi: 10.1097/00004872-200305002-00008. J Hypertens Suppl. 2003. PMID: 12929907 Review.
619 results